Literature DB >> 7202882

Buformin concentrations in a case of fatal lactic acidosis.

L F Verdonck, B Sangster, A N van Heijst, G de Groot, R A Maes.   

Abstract

A fatal case of lactic acidosis in a 84 year old diabetic woman taking buformin is reported. Buformin concentrations in serum, other body fluids and tissues were measured by gas chromatography. Serum buformin concentration at admission was 5.5 mg/l. Postmortem concentrations were: in serum 3.2 mg/l; in lung 2.8 mg/kg wet weight; in heart 3.0 mg/kg; in pericardial fluid 3.5 mg/l; in liver 5.2 mg/kg; in bile 6.3 mg/l; and in kidney 98 mg/kg.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7202882     DOI: 10.1007/bf00253815

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  13 in total

1.  [10 cases of lactic acidosis during biguanide therapy (buformin and phenformin)].

Authors:  W Berger; S Mehnert-Aner; K Mülly; C Heierli; R Ritz
Journal:  Schweiz Med Wochenschr       Date:  1976-12-11

2.  [Investigations of the mode action of buformin using a 3H-labelled glucose in people with a healthy metabolism (author's transl)].

Authors:  P Bottermann; U Schweigart; R Ermler
Journal:  Med Klin       Date:  1976-09-03

3.  Butylbiguanide concentration in plasma, liver, and intestine after intravenous and oral administration to man.

Authors:  W Lintz; W Berger; W Aenishaenslin; V Kutova; C Baerlocher; J P Kapp; R Beckmann
Journal:  Eur J Clin Pharmacol       Date:  1974-10-04       Impact factor: 2.953

4.  Effects of acute lactic acidosis on left ventricular performance.

Authors:  K Wildenthal; D S Mierzwiak; R W Myers; J H Mitchell
Journal:  Am J Physiol       Date:  1968-06

5.  Lactic acidosis.

Authors:  K G Alberti; M Nattrass
Journal:  Lancet       Date:  1977-07-02       Impact factor: 79.321

6.  Effects of changes of pH and of carbon dioxide tension on left ventricular performance.

Authors:  M L Ng; M N Levy; H A Zieske
Journal:  Am J Physiol       Date:  1967-07

7.  [The risk of lacticate acidosis: a comparison of the 3 biguanides in treatment of diabetics (authors' transl)].

Authors:  K Irsigler; H Kritz; H Regal; E Foltin
Journal:  Wien Klin Wochenschr       Date:  1978-05-12       Impact factor: 1.704

8.  [Lactacidosis in biguanide therapy: diagnosis and therapy. 4 cases compared to 179 cases in the world literature].

Authors:  J Zähringer; J Cyran; B Lüderitz
Journal:  Schweiz Med Wochenschr       Date:  1978-11-25

9.  [Lactic acidosis--a possible complication in buformin-treated diabetics (author's transl)].

Authors:  D Deppermann; A Heidland; E Ritz; W Hörl
Journal:  Klin Wochenschr       Date:  1978-09-01

10.  Evaluation of a sustained release form of the oral antidiabetic butylbiguanide (Silubin retard).

Authors:  R Beckmann; W Lintz; E Schmidt-Böthelt
Journal:  Eur J Clin Pharmacol       Date:  1971-09       Impact factor: 2.953

View more
  1 in total

Review 1.  Pharmacokinetic-pharmacodynamic relationships of oral hypoglycaemic agents. An update.

Authors:  P Marchetti; R Navalesi
Journal:  Clin Pharmacokinet       Date:  1989-02       Impact factor: 6.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.